MEDINDIA
English
हिन्दी
Español
français
中文
NEW YORK, Dec. 15 Reportlinker.com announces that a new market research report is available in its catalogue:
Bladder Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
http://www.reportlinker.com/p0167295/Bladder-Cancer---Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html
Bladder Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Summary
GlobalData, the industry analysis specialist's new report, "Bladder Cancer - Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global bladder cancer market. The report identifies the key trends shaping and driving the global bladder cancer market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global bladder cancer sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.
Scope
The scope of the report includes:
- Annualized global bladder cancer market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
- Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
- Analysis of the current and future market competition in the global bladder cancer market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with bladder cancer.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global bladder cancer market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global bladder cancer market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the global bladder cancer market landscape? - Identify, understand and capitalize.
Table of Contents
1 Bladder Cancer Market: Executive Summary
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Bladder Cancer Market: Market Characterization
3.1 Overview
3.2 Bladder Cancer Market Size
3.3 Bladder Cancer Market Forecast and CAGR
3.4 Drivers and Barriers for Bladder Cancer Market
3.4.1 Drivers for Bladder Cancer Market
3.4.2 Barriers for Bladder Cancer Market
3.5 Opportunity and Unmet Need
3.6 Key Takeaway
4 Bladder Cancer Market: Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles of the Major Marketed Products
4.3.1 Overview
4.3.2 Efficacy
4.3.3 Safety Profile
4.3.4 Pricing
4.3.5 Clinical Study Details
4.4 Key Takeaway
5 Bladder Cancer Market: Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.2.1 Technology Trends Analytical Framework
5.3 Bladder Cancer Therapeutics - Promising Drugs under Clinical Development
5.4 Molecule Profiles of Promising Drugs under Clinical Development
5.4.1. Overview
5.4.2 Efficacy
5.4.3 Safety
5.4.4 Clinical Study Details
5.5 Bladder Cancer Therapeutics Market - Clinical Pipeline by Mechanism of Action
5.6 Bladder Cancer Pipeline - Pipeline by Clinical Phases of Development
5.6.1 Bladder Cancer Therapeutics - Phase III Clinical Pipeline
5.6.2 Bladder Cancer Therapeutics - Phase II Clinical Pipeline
5.6.3 Bladder Cancer Therapeutics - Phase I Clinical Pipeline
5.6.4 Bladder Cancer Therapeutics - Preclinical Pipeline
5.6.5 Bladder Cancer Therapeutics - Discovery Pipeline
5.7 Discontinued / Suspended Drugs for Bladder Cancer
5.8 Key Takeaway
6 Bladder Cancer Market: Implications for Future Market Competition
7 Bladder Cancer Market: Future Players in Bladder Cancer Market
8 Bladder Cancer Market: Appendix
8.1 Definitions
8.2 Acronyms
8.3 Research Methodology
8.3.1 Coverage
8.3.2 Secondary Research
8.3.3 Forecasting
8.3.3.1 Epidemiology-based Forecasting
8.3.4 Primary Research
8.3.5 Expert Panel validation
8.4 Contact Us
8.5 Disclaimer
8.6 Sources
List of Tables
Table 1: Global Bladder Cancer Treatment by Stage of the Disease, 2009
Table 2: Global Bladder Cancer Therapeutics Market, Revenue Forecasts ($ m), 2001-2009
Table 3: Global Bladder Cancer Therapeutics Market, Revenue Forecasts ($ m), 2009-2016
Table 4: Major marketed products comparison in Bladder Cancer, 2009
Table 5: Bladder Cancer Therapeutics - Most Promising Drugs Under Clinical Development, 2009
Table 6: Bladder Cancer Therapeutics - Phase III Clinical Pipeline, 2009
Table 7: Bladder Cancer Therapeutics - Phase II Clinical Pipeline, 2009
Table 8: Bladder Cancer Therapeutics - Phase I Clinical Pipeline, 2009
Table 9: Bladder Cancer Therapeutics - Preclinical Pipeline, 2009
Table 10: Bladder Cancer Therapeutics - Drug Discovery Pipeline, 2009
Table 11: Bladder Cancer Therapeutics - List of Discontinued Drugs, 2009
List of Figures
Figure 1: Global Bladder Cancer Therapeutics Market Forecast, 2000-2015
Figure 2: Bladder Cancer Therapeutics Market - Opportunity and Unmet Need, 2009
Figure 3: Bladder Cancer Therapeutics Market - Strategic Competitor Assessment, 2009
Figure 4: Technology Trends Analytic Framework of the Bladder Cancer Pipeline, 2009
Figure 5: Technology Trends Analytic Framework of the Bladder Cancer Pipeline - Description, 2009
Figure 6: Bladder Cancer Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2009
Figure 7: Bladder Cancer Pipeline by Phase of Clinical Development, 2009
Figure 8: Bladder Cancer Therapeutics Market - Strategic Competitor Assessment, 2009
Figure 9: Bladder Cancer Therapeutics Market - Clinical Pipeline by Company, 2009
Figure 10: GlobalData Methodology
Figure 11: GlobalData Market Forecasting Model
To order this report:
Pharmaceutical Industry: Bladder Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
More Market Research Report
Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
